JP2004525940A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525940A5
JP2004525940A5 JP2002576957A JP2002576957A JP2004525940A5 JP 2004525940 A5 JP2004525940 A5 JP 2004525940A5 JP 2002576957 A JP2002576957 A JP 2002576957A JP 2002576957 A JP2002576957 A JP 2002576957A JP 2004525940 A5 JP2004525940 A5 JP 2004525940A5
Authority
JP
Japan
Prior art keywords
duloxetine
use according
raloxifene
hot flashes
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002576957A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525940A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/005113 external-priority patent/WO2002078691A1/en
Publication of JP2004525940A publication Critical patent/JP2004525940A/ja
Publication of JP2004525940A5 publication Critical patent/JP2004525940A5/ja
Pending legal-status Critical Current

Links

JP2002576957A 2001-03-29 2002-03-15 火照りの処置のためのデュロキセチン Pending JP2004525940A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27989601P 2001-03-29 2001-03-29
US34808402P 2002-01-11 2002-01-11
PCT/US2002/005113 WO2002078691A1 (en) 2001-03-29 2002-03-15 Duloxetine for treatment of hot flashes

Publications (2)

Publication Number Publication Date
JP2004525940A JP2004525940A (ja) 2004-08-26
JP2004525940A5 true JP2004525940A5 (cg-RX-API-DMAC7.html) 2005-12-22

Family

ID=26959949

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002576957A Pending JP2004525940A (ja) 2001-03-29 2002-03-15 火照りの処置のためのデュロキセチン

Country Status (4)

Country Link
EP (1) EP1383495A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004525940A (cg-RX-API-DMAC7.html)
CA (1) CA2442410A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002078691A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050049476A (ko) * 2002-08-14 2005-05-25 파마시아 앤드 업존 캄파니 엘엘씨 홍조를 치료하기 위한 레복세틴의 용도
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
KR20060121178A (ko) * 2003-12-12 2006-11-28 일라이 릴리 앤드 캄파니 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US20100285123A1 (en) * 2005-06-20 2010-11-11 Rudresha Korlakunte Virupakshalah Prasad Controlled Release Dosage Formulation of Duloxetine
SG11201708162UA (en) * 2015-04-07 2017-11-29 Meiji Co Ltd Hot flash-suppressing agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
PT888330E (pt) * 1996-03-11 2003-09-30 Lilly Co Eli Metodos de tratamento ou prevencao de cistite intersticial
AU3306399A (en) * 1998-03-02 1999-09-20 Eli Lilly And Company Fluoxetine hydrochloride for decreasing hot flashes

Similar Documents

Publication Publication Date Title
JP2004525940A5 (cg-RX-API-DMAC7.html)
JP2006501240A5 (cg-RX-API-DMAC7.html)
JP2014528901A5 (cg-RX-API-DMAC7.html)
JP2017057230A5 (cg-RX-API-DMAC7.html)
JP2005512995A5 (cg-RX-API-DMAC7.html)
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
JP2006522006A5 (cg-RX-API-DMAC7.html)
JP2002502871A5 (cg-RX-API-DMAC7.html)
NO20014519L (no) Apomorfin- og sildenafilpreparat
ATE339954T1 (de) Kombinationen von formoterol und tiotropium-salz
MY126555A (en) Oral pharmaceutical extended release dosage form
JP2010502762A5 (cg-RX-API-DMAC7.html)
JP2021535107A5 (cg-RX-API-DMAC7.html)
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
JP2005508955A5 (cg-RX-API-DMAC7.html)
RU2004135563A (ru) Лекарственное средство для лечения повышенной активности мочевого пузыря
ME02474B (me) Terapijski režimi
JP2005508963A5 (cg-RX-API-DMAC7.html)
TNSN07474A1 (en) Dosage regimen for prasugrel
JP2005500277A5 (cg-RX-API-DMAC7.html)
JP2002540148A5 (cg-RX-API-DMAC7.html)
JP2003528919A5 (cg-RX-API-DMAC7.html)
JP2022512158A5 (cg-RX-API-DMAC7.html)
JP2023516753A5 (cg-RX-API-DMAC7.html)
JP2002535286A5 (cg-RX-API-DMAC7.html)